Methotrexate in CD
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn’s disease
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn’s disease
Early determinants of IBD use of two national longitudinal birth cohorts (Nested case-controls. UK)